New Appointments To The British Pharmacopoeia Commission
Main Category: Pharma Industry / Biotech IndustryArticle Date: 22 Jan 2010 - 7:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The British Pharmacopoeia (BP) Commission and the Appointments Commission are pleased to announce the appointment and re-appointment of members to the BP Commission.
The BP Commission is responsible for preparing new editions of the BP and the BP (Veterinary) and for keeping them up to date. It also provides advice to the United Kingdom delegation to the European Pharmacopoeia Commission and devises British Approved Names.
Two new appointments were made with effect from 1 January 2010 for a period of four years. The new members are:
Dr Graham Cook is a pharmacist and Senior Director in the Global Quality and Compliance Division of Wyeth Pharmaceuticals.
Dr Brian Matthews is a pharmacist and currently a member of the BP Commission's Expert Advisory Group on Pharmacy, the Panel of Experts on Microbiology and the Working Party on Excipients. He previously held the position of Senior Director, EC registration at Alcon Laboratories.
Professor David Woolfson has been re-appointed for a further four-year term as Chairman with effect from 1 January 2010.
The following members have also been re-appointed from 1 January 2010, for periods of two or four years:
Professor G Buckton
Professor D Cairns
Mr B Capon
Professor A G Davidson
Dr T D Duffy
Mr C T Goddard
Dr R L Horder
Dr L Tsang
Mrs J Turnbull
Professor E Williamson
These appointments are not remunerated; however a fee of £275 per meeting is paid to cover preparation and attendance, together with any travel and subsistence costs. All members are required to comply with the BP Commission's Code of Practice relating to interests in the pharmaceutical industry.
All appointments are made on merit. Political activity plays no part in the selection process. In accordance with the original Nolan Recommendations there is a requirement for appointees' political activity (if declared) to be made public.
The appointments have been made in accordance with the Commissioner for Public Appointments' Code of Practice.
Source
MHRA
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/176836.php>
APA
http://www.medicalnewstoday.com/releases/176836.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



